NCT06716775View on ClinicalTrials.gov

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

October 30, 2028

Conditions
NSCLC Brain Metastasis
Interventions
DEVICE

Tumor treating felds (TTF)

Tumor Treating Fields will be administered continuously with a planned ≥ 18 h per day.

OTHER

Best Standard of Care

Patients will be treated with the best known standard of care for NSCLC brain metastasis and undergo SRS alone.

All Listed Sponsors
collaborator

Shandong Cancer Hospital and Institute

OTHER

lead

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

INDUSTRY

NCT06716775 - Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer. | Biotech Hunter | Biotech Hunter